June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.See Full Update

AIDS vaccine protects 1/3 of people in Thai trial

Published 09/24/2009, 02:00 AM
Updated 09/24/2009, 02:03 AM
SASY
-

WASHINGTON, Sept 24 (Reuters) - An experimental AIDS vaccine made using two older vaccines protected volunteers, lowering the risk of infection by about a third, U.S. and Thai researchers reported on Thursday.

The vaccine is a combination of Sanofi-Aventis' ALVAC canary pox vaccine and the failed HIV vaccine AIDSVAX, made by VaxGen and now owned by the nonprofit Global Solutions for Infectious Diseases.

It lowered the risk of HIV infection by 32 percent among 16,000 heterosexual Thai volunteers who had no special risk of AIDS infection, the U.S. and Thai government researchers said.

(Editing by Julie Steenhuysen and Sandra Maler)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.